From the publishers of JADPRO

Gastrointestinal Stromal Tumor Resource Center

Advertisement

Impact of systemic steroids on the efficacy of first line imatinib treatment of patients with advanced gastrointestinal stromal tumors (GISTs)

Last Updated: Wednesday, January 22, 2025

This study examined 277 GIST patients, finding that systemic steroids used to manage imatinib-induced skin rash did not negatively impact treatment efficacy. There was no significant difference in progression-free survival or overall survival between those using steroids and the control group. 

BMC Cancer
Advertisement
News & Literature Highlights
Advertisement
Advertisement